Patents by Inventor Seth Lawrence Schor

Seth Lawrence Schor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8962615
    Abstract: The described invention relates to compounds (I) which modulate cell migration, and find use in, for example, wound healing, cancer progression and angiogenesis. All definitions as in claim 1.
    Type: Grant
    Filed: June 29, 2012
    Date of Patent: February 24, 2015
    Assignee: University of Dundee
    Inventors: Ana Maria Schor, Seth Lawrence Schor, Rodolfo Marquez, David George Norman
  • Publication number: 20120264746
    Abstract: The described invention relates to compounds (I) which modulate cell migration, and find use in, for example, wound healing, cancer progression and angiogenesis. All definitions as in claim 1.
    Type: Application
    Filed: June 29, 2012
    Publication date: October 18, 2012
    Inventors: Ana Maria Schor, Seth Lawrence Schor, Rodolfo Marquez, David George Norman
  • Patent number: 8242108
    Abstract: The described invention relates to compounds which modulate cell migration, and find use in, for example, wound healing, cancer progression and angiogenesis.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: August 14, 2012
    Assignee: University of Dundee
    Inventors: Ana Maria Schor, Seth Lawrence Schor, Rodolfo Marquez, David George Norman
  • Patent number: 7811789
    Abstract: A recombinant polynucleotide encoding migrating stimulating factor (MSF) or variants or fragments or derivatives or fusions thereof or fusions of said variants or fragments or derivatives. Reagents are disclosed which can distinguish MSF and fibronectin, and which can distinguish polynucleotides which encode MSF or fibronectin. These reagents are believed to be useful in, for example, diagnosing cancer. MSF or variants or fragments or derivatives or fusions thereof, or fusions of said variants or fusions or derivatives, are useful in modulating cell migration and in wound healing.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: October 12, 2010
    Assignee: University of Dundee
    Inventors: Seth Lawrence Schor, Ana Maria Schor
  • Publication number: 20090221561
    Abstract: The described invention relates to compounds which modulate cell migration, and find use in, for example, wound healing, cancer progression and angiogenesis.
    Type: Application
    Filed: August 23, 2006
    Publication date: September 3, 2009
    Inventors: Ana Maria Schor, Seth Lawrence Schor, Rodolfo Marquez, David George Norman
  • Publication number: 20080187962
    Abstract: A recombinant polynucleotide encoding migrating stimulating factor (MSF) or variants or fragments or derivatives or fusions thereof or fusions of said variants or fragments or derivatives. Reagents are disclosed which can distinghish MSF and fibronectin, and which can distinguish polynucleotides which encode MSF or fibronectin. These reagents are believed to be useful in, for example, diagnosing cancer. MSF or variants or fragments or derivatives or fusions thereof, or fusions of said variants or fusions or derivatives, are useful in modulating cell migration and in wound healing.
    Type: Application
    Filed: October 30, 2007
    Publication date: August 7, 2008
    Applicant: UNIVERSITY OF DUNDEE
    Inventors: Seth Lawrence Schor, Ana Maria Schor
  • Patent number: 7351810
    Abstract: A recombinant polynucleotide encoding migrating stimulating factor (MSF) or variants or fragments or derivatives or fusions thereof or fusions of said variants or fragments or derivatives. Reagents are disclosed which can distinguish MSF and fibronectin, and which can distinguish polynucleotides which encode MSF or fibronectin. These reagents are believed to be useful in, for example, diagnosing cancer. MSF or variants or fragments or derivatives or fusions thereof, or fusions of said variants or fusions or derivatives, are useful in modulating cell migration and in wound healing.
    Type: Grant
    Filed: December 15, 1998
    Date of Patent: April 1, 2008
    Assignee: University of Dundee
    Inventors: Seth Lawrence Schor, Ana Maria Schor
  • Patent number: 7109160
    Abstract: A compound with a relative molecular mass of less than 15000 comprising the peptide Ile-Gly-Asp (IGD) or a peptide or non-peptide mimic thereof. The compounds may be used to modulate cell migration and are useful in angiogenesis.
    Type: Grant
    Filed: July 1, 1998
    Date of Patent: September 19, 2006
    Assignee: University of Dundee
    Inventor: Seth Lawrence Schor